Leishmania in HLH: A rare finding with significant treatment implications

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 3, 2013, Pages

  Singh, Gurpreet ^a   Shabani Rad, Meer Taher ^b   Vanderkooi, Otto G ^c,d,e   Vayalumkal, Joseph V ^b   Kuhn, Susan M ^a,f   Guilcher, Gregory M T ^b   Steele, MacGregor ^g  

^a UNIVERSITY OF CALGARY   (Canada)

^b Department of Pathology and Laboratory Medicine ^*  (Canada)

^c Pediatric Infectious Diseases Medical Microbiology and Tropical Medicine   (Canada)

^d Pediatric Infectious Diseases Residency Training Program   (Canada)

^e Department of Pediatrics Microbiology and Infectious Diseases Pathology and Laboratory Medicine   (Canada)

^f ALBERTA HEALTH SERVICES   (Canada)

^g ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Hemophagocytic lymphohistiocytosis; Stem cell transplant; Travel history; Visceral leishmaniasis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B LIPID COMPLEX; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; FERRITIN; FIBRINOGEN; HEMOGLOBIN; IMMUNOGLOBULIN M; INTERLEUKIN 2; TRIACYLGLYCEROL; VIRUS CAPSID ANTIGEN;

ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; EPSTEIN BARR VIRUS INFECTION; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; MALE; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PANCYTOPENIA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; RECURRENT DISEASE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRAVEL; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; HUMANS; INFANT; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; TREATMENT OUTCOME;

EID: 84876124438     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318286d619     Document Type: Article

References (12)

1. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166: 95-109.
2. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48: 124-131.
3. Maakaroun NR, Moanna A, Jacob JT, et al. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20: 93-105.
4. Rajagopala S, Dutta U, Chandra KS, et al. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis - case report and systematic review. J Infect. 2008;56: 381-388.
5. Murray HW. Kala-azar - progress against a neglected disease. N Engl J Med. 2002;347: 1793-1794.
6. Neuber H. Leishmaniasis. J Dtsch Dermatol Ges. 2008;6: 754-765.
7. Umit Celik, Derya Alabaz, Emre Alhan, et al. Diagnostic dilemma in an adolescent boy: hemophagocytic syndrome in association with kala azar. Am J Med Sci. 2007;334: 139-141.
8. Makaritsis KP, Gatselis NK, Ioannou M, et al. Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis. Int J Infect Dis. 2009;13:e157-e160.
9. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5: 873-882.
10. Gagnaire MH, Galambrun C, Stephan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children - a series of 12 cases. Pediatrics. 2000;106:E58.
11. Bogdan C, Schonian G, Banuls AL, et al. Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clin Infect Dis. 2001;32: 302-306.
12. Bosnic S, Gradoni L, Khoury C, et al. A review of leishmaniasis in Dalmatia (Croatia) and results from recent surveys on phlebotomine sandflies in three southern counties. Acta Trop. 2006;99: 42-49.